Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Pulmonary Embolism and COVID-19, an Unexpected Association: Experience from Two Centers in the Core of the Infection Italian Peak
23 Pages Posted: 2 Jun 2020
More...Abstract
Background: Pulmonary embolism (PE) in COVID-19 patients can play a key role in precipitating clinical conditions. We aimed to evaluate PE distribution on CTA images and to investigate any possible association between PE and D-dimer, pulmonary stage of disease and short-term prognosis.
Methods: COVID-19 patients of two affiliated Hospitals, undergone a CTA examination for PE clinical suspicion, were retrospectively enrolled. Comorbidities, laboratory tests and clinical outcomes (hospitalization, discharge, death) were assessed. The assigned parenchymal stages (early, progressive, peak, absorption) described lung involvement as showed on CT images.
Findings: A cohort of 114 patients (mean age 61 years; 26·3% females) with COVID-19 pneumonia were evaluated. At follow-up 77 patients (67·5%) were hospitalized, 25 (22%) have been discharged and 12 (10.5%) were dead. Eighty-eight patients (77·2%) had at least one comorbidity, being cardiovascular ones the most frequent (44·7%). CTA revealed PE in 65 patients (57%), with concomitant pulmonary trunk and/or main arteries involvement in 16·9% cases. PE defects were ubiquitous in 18·5% of cases. The predominant parenchymal stages were the progressive (24·6%) and peak (67·7%) ones. D-dimer levels showed a significant correlation with PE occurrence and extent in pulmonary branches, despite anticoagulant therapies; trend of correlation with pulmonary stage was also noted.
Interpretation: PE is a frequent complication in COVID-19 patients, particularly during central parenchymal stages and despite ongoing anticoagulant therapy. CTA and D-dimer levels play a crucial role in the assessment of suspected PE, despite anticoagulant therapies, along with proper information about lung involvement extent.
Funding Statement: None.
Declaration of Interests: The authors declare no competing interests.
Ethics Approval Statement: The ethical approval for this retrospective study was obtained from the local ethics committee of Papa Giovanni XXIII Hospital, Bergamo.
Keywords: COVID-19; Severe acute respiratory syndrome coronavirus 2; Pneumonia; Pulmonary Embolism
Suggested Citation: Suggested Citation